331A — Medix Balance Sheet
0.000.00%
- ¥4bn
- ¥486m
- ¥4bn
- 82
- 86
- 20
- 71
Annual balance sheet for Medix, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.
2023 March 31st | 2024 March 31st | 2025 March 31st | |
---|---|---|---|
Period Length: | — | — | — |
Source: | PROSPECTUS | PROSPECTUS | Tanshin |
Standards: | JAS | JAS | — |
Status: | Final | Final | Final |
Cash and Equivalents | |||
Cash and Short Term Investments | 2,364 | 2,780 | 3,771 |
Net Total Accounts Receivable | |||
Net Total Receivables | 2,242 | 2,293 | 2,227 |
Prepaid Expenses | |||
Total Other Current Assets | |||
Total Current Assets | 4,715 | 5,175 | 6,102 |
Gross Property, Plant And Equipment | |||
Accumulated Depreciation | |||
Net Property, Plant And Equipment | 112 | 132 | 115 |
Net Intangible Assets | |||
Long Term Investments | |||
Long Term Notes Receivable | |||
Other Long Term Assets | |||
Total Assets | 5,432 | 5,904 | 6,670 |
Accrued Expenses | |||
Notes Payable / Short Term Debt | |||
Current Portion of Long Term Debt / Capital Leases | |||
Total Other Current Liabilities | |||
Total Current Liabilities | 2,962 | 3,125 | 2,833 |
Long Term Debt | |||
Capital Lease Obligations | |||
Total Long Term Debt | |||
Total Debt | |||
Total Other Liabilities | |||
Total Funded Status | |||
Total Liabilities | 3,702 | 3,747 | 3,401 |
Common Stock | |||
Additional Paid In Capital | |||
Retained Earnings (Accumulated Deficit) | |||
Treasury Stock | |||
Total Equity | 1,730 | 2,157 | 3,269 |
Total Liabilities & Shareholders' Equity | 5,432 | 5,904 | 6,670 |
Total Common Shares Outstanding |